MSL / Sr MSL, Hematology - Northern California
Sobi
Summary
The Medical Science Liaison (MSL) is a highly trained, field-based scientific expert who engages healthcare professionals (HCPs) to exchange clinical, scientific, and research knowledge. Operating within regulatory and corporate guidelines, the MSL builds and maintains scientific relationships and collaborations with the medical and scientific community at the local, regional, and national levels.
Job description
Territory & Travel
Assigned Territory: Northern California. This role provides educational, scientific, and research support for Sobi's rare disease portfolio within the hematology franchise. Frequent travel by ground and/or air is required, with an estimated 60% or more of time away from the remote home office.
Essential Responsibilities
- Serve as the primary field-based point of contact for Sobi Medical Affairs within the Northern California territory.
- Engage key thought leaders and healthcare professionals to exchange scientific information accurately, fairly, and in a balanced manner.
- Report field intelligence, including competitive insights, perspectives on compounds, disease states, and the treatment landscape.
- Support clinical development and operations teams through site recommendations, site initiation visits, communication facilitation, and accrual support.
- Participate in, and at times lead, advisory board meetings at the local, regional, and national levels.
- Deliver internal and external training on preclinical science, clinical data, and outcomes.
- Represent Sobi at medical conferences and provide session summaries.
- Serve as a cross-functional scientific resource across the organization.
- Maintain advanced, current knowledge of relevant studies, compounds, and disease states to support scientific discussions with hematology/oncology thought leaders.
- Manage the assigned Northern California territory while contributing to the success of colleagues and the broader MSL organization.
Requirements
- Accredited doctorate degree in a life-science or basic-science discipline (Pharm.D., D.Sc., D.N.P., Ph.D., or M.D./D.O.)
- Advanced health-related degree combined with extensive industry or clinical experience will also be considered
- Minimum of 1 year of MSL experience in hematology/oncology and rare disease
- Existing familiarity with the Northern California medical/scientific community and key institutions
- Ability to understand and effectively communicate scientific information
- Strong written and oral communication skills
- Demonstrated success managing internal and external stakeholders and leading or influencing cross-functional teams in a matrixed environment
- Proven ability to prioritize and manage multiple projects concurrently
- Proven track record of strategic thinking, problem-solving, and decision-making
- Ability to initiate and maintain relationships throughout the medical community
- Demonstrated ability to build positive, constructive relationships with cross-functional internal team members
- High level of personal integrity, emotional intelligence, and flexibility
- Understanding of the highly regulated biopharmaceutical industry environment, including basic knowledge of the legal and regulatory landscape
- Passion for science and teaching
Benefits
- 401(k) Matching
- Tuition Reimbursement
- Wellness Reimbursement
- Medical, Dental & Vision
- Recognition Awards
- Generous Time Off Policy
- Short-term and Long-term Bonuses
Company overview
Sobi, officially known as Swedish Orphan Biovitrum AB, is an international specialty biopharmaceutical company headquartered in Stockholm, Sweden, dedicated to transforming the lives of people with rare diseases. The company focuses on developing and commercializing breakthrough therapies in three key therapeutic areas: haematology, immunology, and specialty care. With a strong commitment to rare diseases, Sobi addresses conditions affecting small patient populations that often have limited treatment options. The company's product portfolio includes innovative treatments for haemophilia, immune thrombocytopenia, paroxysmal nocturnal haemoglobinuria, familial Mediterranean fever, cryopyrin-associated periodic syndromes, and respiratory syncytial virus. Listed on Nasdaq Stockholm under the ticker SOBI, Sobi operates globally with approximately 1,600 employees across 32 countries. The company emphasizes patient-centric approaches, strategic partnerships, and sustainable business practices while maintaining a robust pipeline of innovative medicines to address unmet medical needs in rare disease communities worldwide.